FDA Drug recall D-0052-2025
Ramipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 count (NDC 68180-589-02) bottles,…
- FDA Drug
- Class II
- terminated
- Published 2024-11-27
On 2024-11-27 the FDA classified a Class II recall of Ramipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 count (NDC 68180-589-02) bottles,… by Lupin Pharmaceuticals, citing CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0052-2025 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-10-23 |
| Published | 2024-11-27 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Ramipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 count (NDC 68180-589-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India
Reason
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Identifiers
| ndc | 68180-589-09 |
|---|---|
| ndc | 68180-589-10 |
| ndc | 68180-589-01 |
| ndc | 68180-589-02 |
| ndc | 68180-590-09 |
| ndc | 68180-590-10 |
| ndc | 68180-590-01 |
| ndc | 68180-590-02 |
| ndc | 68180-591-09 |
| ndc | 68180-591-10 |
| ndc | 68180-591-02 |
| ndc | 68180-591-01 |
| ndc | 68180-588-01 |
| ndc | 68180-588-02 |
| ndc | 68180-588-09 |
| code_info | a) NDC 68180-589-09; Lots G326781, exp. date 30-Sep-25, GA04468, exp. date 31-May-25 b) NDC 68180-589-01; Lots G32…a) NDC 68180-589-09; Lots G326781, exp. date 30-Sep-25, GA04468, exp. date 31-May-25 b) NDC 68180-589-01; Lots G326763, exp. date 30-Sep-25, GA03041, exp. date 31-Mar-26, GA03725, exp. date 30-Apr-26, GA04402, exp. date 31-May-26, c) NDC 68180-589-02; Lots G326782, exp. date 30-Sep-25, GA04462, exp. date 31-May-26 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0052-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.